期刊文献+

基于细胞信号动态网络的药物靶点发现 被引量:19

Drug targets discovery based on dynamic signal transduction networks
原文传递
导出
摘要 药物发现一直以来都集中在寻找疾病过程中某个特定步骤或蛋白质靶点的高特异性的抑制剂上。但是这样高特异性的药物对于如肿瘤、糖尿病、老年痴呆症和神经精神疾病等复杂疾病,治疗效果通常不佳,因此需要重新考虑药物靶点的选择和药物开发的策略。本文将介绍疾病相关的细胞信号转导分子网络及其动态学变化、信号网络的特性及其研究方法,以及构建模型的相关网络资源和工具。重点阐述将信号转导动态网络作为药物靶标的策略方法和过程,包括多靶点药物设计及基于网络的药物研究。 Since last century, drug discovery efforts mostly focus on searching for chemicals which can inhibit some specific steps in a well-described disease pathway. However, this kind of highly specific inhibitors can not be effective for complex diseases, like cancer, diabetes, schizophrenia and mental illness. Therefore, we need to rethink the drug discovery and therapeutic strategies. In this review, the strategies of selection of cellular signal transduction networks and their dynamics as the targets for drug discovery and pharmacological treatments will be discussed. The properties and analytical methods of these signal transduction networks, internet sources and software tools for performing these strategies will be described. Strategies and procedures of using network- based drug discovery will be emphasized, including multi-targets drug design and network-based drug discovery.
作者 王娟 李学军
出处 《药学学报》 CAS CSCD 北大核心 2010年第1期1-8,共8页 Acta Pharmaceutica Sinica
关键词 细胞信号转导网络 系统生物学 系统建模 药物靶点 cellular signal transduction network systems biology system modeling drug target
  • 相关文献

参考文献2

二级参考文献66

  • 1Miller DK, Gillard JW, Vickers P J, et al. Identification and isolation of a membrane-protein necessary for leukotriene production [J]. Nature, 1990, 343: 278-281.
  • 2Tsuji F, Oki K, Fujisawa K, et al. Involvement of leukotriene B4 in arthritis models [J]. Life Sci, 1998, 64: 151-156.
  • 3Penning TD. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents [J]. Curr Pharm Des, 2001, 7: 163-179.
  • 4Penning TD, Chandrakumar NS, Desai BN, et al. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase [J]. Bioorg Med Chem Lett, 2003, 13: 1137-1139.
  • 5Grice CA, Tays KL, Savall BM, et al. Identification of a potent, selective, and orally active leukotriene A4 hydrolase inhibitor with anti-inflammatory activity [J]. J Med Chem, 2008, 51: 4150-4169.
  • 6Ye B, Bauman J, Chen M, et al. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase [J]. Bioorg Med Chem Lett, 2008, 18: 3891-3894.
  • 7Haeggstrom JZ. Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis [J]. J Biol Chem, 2004, 279: 50639-50642.
  • 8Thunnissen MM, Andersson B, Samuelsson B, et al. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors [J]. FASEB J, 2002, 16: 1648-1650.
  • 9Schrattenholz A, Soskic V. What does systems biology mean for drug development? [J]. Curr Med Chem, 2008, 15: 1520- 1528.
  • 10Yang K, Bai HJ, Ouyang Q, et al. Finding multiple target optimal intervention in disease-related molecular network [J]. Mol Syst Biol, 2008, 4: 228.

共引文献29

同被引文献278

引证文献19

二级引证文献432

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部